Advertisement
Screener

COMPASS PATHWAYS PLC (CMPS) Cash Flow Breakdown

COMPASS PATHWAYS PLC Cash Flow Breakdown

Cash flow breakdown shows where COMPASS PATHWAYS PLC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $157.24M went out.
  • Fiscal year ended 2025-12-31: from financing, $140.71M came in.
  • Fiscal year ended 2025-12-31: change in cash, $15.48M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$157.24M$0.00$140.36M-$15.48M
2024-12-31-$119.19M$0.00$0.00-$239.00K$26.22M$37.84M*-$55.17M
2023-12-31-$97.38M-$64.00K$29.59M-$265.00K$144.94M$77.26M
2022-12-31-$105.45M-$596.00K$0.00$0.00$440.00K$600.00K*-$129.97M
2021-12-31-$67.75M-$334.00K$0.00$0.00$154.79M$1.85M*$82.99M
2020-12-31-$41.38M-$628.00K$0.00$0.00$194.16M*$165.37M
2019-12-31-$17.81M-$165.00K$0.00$18.38M*$2.08M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$40.31M*$0.00*$1.13M*$6.43M*
2026-03-31-$47.94M$18.58M$140.64M$203.23M*$316.40M
2025-12-31-$37.79M*$0.00*$0.00*
2025-09-30-$35.11M*$0.00*$0.00*
2025-06-30-$38.69M*$0.00*$0.00*$9.00K*
2025-03-31-$45.66M$0.00$0.00$140.36M$95.02M
2024-12-31-$41.76M*$0.00*$0.00*-$1.00K*$0.00*
2024-09-30-$22.18M*$0.00*$0.00*-$53.00K*$0.00*
2024-06-30-$34.42M*$0.00*$0.00*$0.00*
2024-03-31-$20.83M$0.00-$185.00K$26.22M$37.48M*$42.64M
2023-12-31-$27.78M*$0.00*$0.00*-$80.00K*-$41.00K*
2023-09-30-$17.06M*-$18.00K*$0.00*-$76.00K*$116.86M*
2023-06-30-$24.81M*-$17.00K*$0.00*$26.93M*$29.00M*
2023-03-31-$27.72M-$29.00K-$109.00K$1.19M-$26.01M
2022-12-31-$45.30M*-$107.00K*$0.00*$0.00*$440.00K*
2022-09-30-$19.02M*$5.00K*$0.00*$0.00*$0.00*
2022-06-30-$18.00M*-$412.00K*$0.00*$0.00*
2022-03-31-$23.12M-$82.00K$0.00$0.00-$29.56M
2021-12-31-$22.37M*-$93.00K*$0.00*$805.00K*
2021-09-30-$13.89M*-$86.00K*$0.00*
2021-06-30-$17.70M*-$85.00K*$0.00*$154.83M*
2021-03-31-$13.78M-$70.00K$998.00K-$10.81M
2020-12-31-$16.75M*-$32.00K*-$132.82M*
2020-09-30-$13.91M*-$15.00K*$76.85M*$61.40M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Septerna, Inc. (SEPN)United States$1.783B-63.01
Xencor Inc (XNCR)United States$1.776B-7.33
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82